Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
The Journal of Pharmacology and Experimental Therapeutics|September 12, 2023
First-in-Human Phase 1 Randomized Trial with the Anti-CD40 Monoclonal Antibody KPL-404: Safety, Tolerability, Receptor Occupancy, and Suppression of T-Cell-Dependent Antibody ResponseManoj Samant, John Ziemniak, John F PaoliniJournal of Medicinal Chemistry|April 16, 2008
Ring size in octreotide amide modulates differently agonist versus antagonist binding affinity and selectivityChristy Rani R Grace, Judit Erchegyi, Manoj Samant, et al.Journal of Medicinal Chemistry|April 16, 2008
Ring size of somatostatin analogues (ODT-8) modulates receptor selectivity and binding affinityJudit Erchegyi, Christy Rani R Grace, Manoj Samant, et al.Journal of Medicinal Chemistry|January 21, 2016
Characterization of Multisubstituted Corticotropin Releasing Factor (CRF) Peptide Antagonists (Astressins)Judit Erchegyi, Lixin Wang, Jozsef Gulyas, et al.Plos One|February 8, 2014
Novel exenatide analogs with peptidic albumin binding domains: potent anti-diabetic agents with extended duration of actionOdile E Levy, Carolyn M Jodka, Shijun Steven Ren, et al.Annals of the Rheumatic Diseases|March 10, 2022
Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trialMaria C Cid, Sebastian H Unizony, Daniel Blockmans, et al.Pageof 1